Articles
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis
- Journal/Conference:
- The Breast
- Author(s):
- Elizabeth M Salvo, Abril Oliva Ramirez, Jenilee Cueto, Ernest H Law, Aaron Situ, Chris Cameron, Imtiaz A Samjoo
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Oncology
- Condition:
- Breast Cancer
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer
- Journal/Conference:
- Journal of Comparative Effectiveness Research
- Author(s):
- Rugo, H. S., Haltner, A., Zhan, L., Tran, A., Bananis, E., Hooper, B., Mitra, D., & Cameron, C.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Oncology
- Condition:
- Breast Cancer
Meta-Analysis of Proptosis Response in Thyroid Eye Disease: Efficacy of EUGOGO Recommended Treatment Regimen With IV Methylprednisolone
- Journal/Conference:
- Journal of the Endocrine Society
- Author(s):
- Douglas, R. S., Batten, R., Qadeer, R.A., Cameron, C.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Vision
- Condition:
- Thyroid Eye Disease
Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain
- Journal/Conference:
- Expert Review of Pharmacoeconomics & Outcomes Research
- Author(s):
- Galan, L.: Gonzalez-Moreno, J.: Martínez-Sesmero, J.M.:Muñoz-Beamud, F.: Santos-Rubio, M.D.: Tran, D.: Lebeau, P.: Stewart, M.: Mallaina, P.: Tarilonte, P.: Peral, C.: Rozenbaum, M.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Nervous System
- Condition:
- Transthyretin amyloid polyneuropathy (ATTR-PN)
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies
- Journal/Conference:
- European Heart Journal - Quality of Care and Clinical Outcomes
- Author(s):
- Rozenbaum, M.H.: Garcia, A.: Grima, D.: Tran, D.: Bhambri, R.: Stewart, M.: Li, B.; Heeg, B.: Postma, M.: Masri, A.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Cardiac
- Condition:
- ATTR cardiomyopathy
Annual Cardiovascular-related Hospitalization Days Avoided With Tafamidis Treatment in Patients With Transthyretin Amyloid Cardiomyopathy
- Journal/Conference:
- Heart Failure Society of America (HFSA) Annual Scientific Meeting 2021 (Sept 10 - 13, 2021; Denver, CO)
- Author(s):
- Rozenbaum, M.: Tran, D.: Bhambri, R.: Nativi-Nicolau, J.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Cardiac
- Condition:
- ATTR cardiomyopathy
Modelling Lifetime Survival Gain in Patients With Transthyretin Amyloid Cardiomyopathy and Baseline NYHA Class III: An Analysis of ATTR-ACT and Long-Term Extension Study
- Journal/Conference:
- Heart Failure Society of America (HFSA) Annual Scientific Meeting 2021 (Sept 10 - 13, 2021; Denver, CO)
- Author(s):
- Rozenbaum, M.: Tran, D.: Li, B.: Bhambri, R.: Postma, M.: Masri, A.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Cardiac
- Condition:
- ATTR cardiomyopathy
Efficacy classification of modern therapies in multiple sclerosis
- Journal/Conference:
- Journal of Comparative Effectiveness Research
- Author(s):
- Samjoo IA, Worthington E, Drudge C, Zhao M, Cameron C, Häring DA, Stoneman D, Klotz L, Adlard N.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Nervous System
- Condition:
- Multiple Sclerosis
Network Meta-analysis of Disease-modifying Therapies for Relapsing Multiple Sclerosis Based on Confirmed Disability Progression: Investigating the Influence of Cross-trial Differences in Endpoint Definition
- Journal/Conference:
- 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 13-15 October 2021 [online]
- Author(s):
- Stoneman D, Drudge C, Zhao M, Worthington E, Cameron C, Haring DA, Samjoo I, Adlard N
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Nervous System
- Condition:
- Multiple Sclerosis
Relapse Reduction by Disease-modifying Therapies for Relapsing Multiple Sclerosis: A Network Meta-analysis
- Journal/Conference:
- 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 13-15 October 2021 [online]
- Author(s):
- Stoneman D, Drudge C, Zhao M, Worthington E, Cameron C, Haring D, Samjoo I, Adlard N
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Nervous System
- Condition:
- Multiple Sclerosis